Doug Hampton 
EMERYVILLE, Calif., Aug. 9, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Company will be reporting financial results for the second quarter 2023 after market on Monday, August 14, 2023. About PhenomeX Inc. PhenomeX is empowering scientists to leverage the full potential of each cell and drive the … Read more
RADNOR, Pa., Aug. 8, 2023 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Connecticut against BioXcel Therapeutics, Inc. (“BioXcel”) (NASDAQ: BTAI). The action charges BioXcel with violations of the federal securities … Read more
REDDITCH, England, Aug. 8, 2023 /PRNewswire/ — Between 31 July 2023 and 4 August 2023 Concentric AB (LEI code 5493002G9GMTKIP3PW19) (“Concentric”) has repurchased in total 14,769 own shares (ISIN: SE0003950864) as part of the repurchase program initiated by the Board. The repurchases form part of the repurchase program of a maximum of 3,519,172 own shares … Read more
BREA, Calif., Aug. 7, 2023 /PRNewswire/ — Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced its intention to offer, subject to market and other conditions, $435,000,000 in aggregate principal amount of Convertible Senior Notes due 2028 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of … Read more
MUMBAI, Inde, 6 août 2023 /PRNewswire/ — Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a annoncé aujourd’hui ses résultats consolidés pour le premier trimestre (T1) clos le 30 juin 2023. Nandini Piramal, Chairperson, Piramal Pharma Limited Faits saillants des résultats financiers consolidés : (En crores INR) Détails T1 Exercice 2024 T1 Exercice 2023 Croissance annuelle T4 Exercice 2023 Croissance trimestrielle … Read more
The PMC Aims to Exceed $970 Million Raised for Dana-Farber Cancer Institute with Most Ambitious Fundraising Goal to Date BOSTON, Aug. 5, 2023 /PRNewswire/ — On Saturday, August 5 and Sunday, August 6, the Pan-Mass Challenge (PMC), the world’s single most successful athletic fundraiser, will bring together 6,500 riders and over 3,000 volunteers for its 44th ride. … Read more
DUBLIN, Aug. 4, 2023 /PRNewswire/ — The “Connected Healthcare Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. The global connected healthcare market grew from $100.03 billion in 2022 to $127.53 billion in 2023 at a compound annual growth rate (CAGR) of 27.5%. The connected healthcare market is expected to grow to $345.49 billion … Read more
BIMERVAX® : une dose de rappel d’un vaccin bivalent à base de protéines recombinantes permet d’immuniser les personnes âgées de plus de 16 ans LONDRES et GERONE, Espagne, 4 août 2023 /PRNewswire/ — Accord Healthcare, Ltd. (Accord) et HIPRA ont annoncé aujourd’hui qu’ils ont conclu un accord de distribution exclusif pour commercialiser le vaccin COVID-19 de HIPRA … Read more
The FDA granted Aardvark Therapeutics a Rare Pediatric Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare genetic disease characterized by extreme and unabating hunger. Aardvark’s Phase 2 trial of oral ARD-101 in young adults with PWS is now open for enrollment of additional subjects. SAN DIEGO, Aug. 3, 2023 /PRNewswire/ — Aardvark Therapeutics, … Read more
DUBLIN, Aug. 2, 2023 /PRNewswire/ — The “Bio Decontamination Market by Product (Equipment, Consumables), Agent (Hydrogen Peroxide, Chlorine Dioxide, Nitrogen Dioxide), Type (Room Decontamination, Chamber Decontamination), End user (Hospital & Healthcare facilities) – Global Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. The global bio decontamination market is projected to reach USD 339 million … Read more